Cannabinoids

CORDOBA, Spain, June 22, 2018 /PRNewswire/ — Phytoplant Research S.L. participated in a first-ever pioneering collaborative project to investigate the ability of cannabinoid cannabigerol (CBG), the molecular precursor of Δ9-tetrahydrocannabinol (Δ 9-THC) and cannabidiol (CBD). The study investigated the ability of the above to modulate the affinity and functionality of type-1 and type-2 cannabinoid receptors (CB1 […]

A scientific study published last year was the latest to focus the research community on the potential of the GPR55 receptor, which is now known to be the third identified receptor in the human endocannabinoid system. The study found a role for the receptor in the use of CBD to treat Dravet syndrome, a rare […]

Home Secretary Sajid Javid has announced a review of the official treatment of cannabis for medicinal use. Cannabis is currently a controlled drug as classified by the Misuse of Drugs Act 1971. A follow-up to this law, the Misuse of Drugs Regulations Act 2001, placed it under Schedule 1, which is the category for substances […]

Pascal Biosciences (TSXV:PAS) has announced that it has been licensed by the US Drug Enforcement Administration (DEA) to conduct and research development on cannabinoids. As quoted in the press release: Pascal is also pleased to renew the UBC collaboration and continue financial support of Dr. Wilfred Jefferies’ laboratory at the Michael Smith Laboratories. Pascal is […]

Pascal Biosciences (TSXV:PAS) has announced that it has been licensed by the US Drug Enforcement Administration (DEA) to conduct and research development on cannabinoids. As quoted in the press release: Pascal is also pleased to renew the UBC collaboration and continue financial support of Dr. Wilfred Jefferies’ laboratory at the Michael Smith Laboratories. Pascal is […]

Pascal Biosciences (TSXV:PAS) has announced that it has been licensed by the US Drug Enforcement Administration (DEA) to conduct and research development on cannabinoids. As quoted in the press release: Pascal is also pleased to renew the UBC collaboration and continue financial support of Dr. Wilfred Jefferies’ laboratory at the Michael Smith Laboratories. Pascal is […]

NanoSphere Health Sciences CSO Dr. Richard Kaufman shares his insight on the role of nanotechnology in next-generation drug-delivery methods. Dr. Richard Kaufman, chief scientific officer for NanoSphere Health Sciences (CSE:NSHS), has developed patented nanoparticle delivery systems that have set him apart as a leader in the medical technology world. Nanotechnology has the potential to disrupt […]

If there’s one thing that almost every person in the world can agree on, it’s that we’re all stressed. And whether they be small stressors like getting stuck in traffic, or large sources of stress like losing a loved one, we encounter stress in one form or another on a daily basis. Fascinating research has […]

Therapix Biosciences Ltd. TRPX , a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that this month, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest private hospital network in Israel. Adi […]

LAS VEGAS, June 12, 2018 (GLOBE NEWSWIRE) — VITALIBIS, INC. (OTCQB:VCBD), a technology-based seller of premium, full spectrum phyto-cannabinoid rich (PCR) hemp oil products, along with personal care and certified organic nutritional products, today announced the launch of its “Pro-Programâ€�.  Marketing and sales within this program are focused on health professionals with offices servicing the […]

About 7000 cases of toxicities associated with synthetic cannabinoids (ie synthetic marijuana, K2, or Spice) are reported annually to US poison control centers, and that reportedly accounted for two-thirds of overall substance abuse between 2005 and 2011. Synthetic cannabinoids were first introduced in the United States in 2008 but have been used in Europe since 2004. […]